These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1765073)

  • 1. Inhibitory activity and conformational transition of alpha 1-proteinase inhibitor variants.
    Schulze AJ; Huber R; Degryse E; Speck D; Bischoff R
    Eur J Biochem; 1991 Dec; 202(3):1147-55. PubMed ID: 1765073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha 1-proteinase inhibitor variant T345R. Influence of P14 residue on substrate and inhibitory pathways.
    Hood DB; Huntington JA; Gettins PG
    Biochemistry; 1994 Jul; 33(28):8538-47. PubMed ID: 8031789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Full or partial substitution of the reactive center loop of alpha-1-proteinase inhibitor by that of heparin cofactor II: P1 Arg is required for maximal thrombin inhibition.
    Filion ML; Bhakta V; Nguyen LH; Liaw PS; Sheffield WP
    Biochemistry; 2004 Nov; 43(46):14864-72. PubMed ID: 15544357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The P6-P2 region of serpins is critical for proteinase inhibition and complex stability.
    Chaillan-Huntington CE; Gettins PG; Huntington JA; Patston PA
    Biochemistry; 1997 Aug; 36(31):9562-70. PubMed ID: 9236002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for the extent of insertion of the active site loop of intact alpha 1 proteinase inhibitor in beta-sheet A.
    Schulze AJ; Frohnert PW; Engh RA; Huber R
    Biochemistry; 1992 Aug; 31(33):7560-5. PubMed ID: 1510942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between protein structure and methionine oxidation in recombinant human alpha 1-antitrypsin.
    Griffiths SW; Cooney CL
    Biochemistry; 2002 May; 41(20):6245-52. PubMed ID: 12009885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single amino acid substitutions in recombinant plant-derived human α1-proteinase inhibitor confer enhanced stability and functional efficacy.
    Jha S; Sanyal I; Amla DV
    Biochim Biophys Acta; 2014 Jan; 1840(1):416-27. PubMed ID: 24090883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidized and Met358-->Leu mutated alpha 1-proteinase inhibitor as substrates of Pseudomonas aeruginosa elastase.
    Padrines M; Bieth JG
    Biochim Biophys Acta; 1993 Apr; 1163(1):61-6. PubMed ID: 8476930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of alpha 1-proteinase inhibitor in Escherichia coli: effects of single amino acid substitutions in the active site loop on aggregate formation.
    Schulze AJ; Degryse E; Speck D; Huber R; Bischoff R
    J Biotechnol; 1994 Feb; 32(3):231-8. PubMed ID: 7764716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of strand 1 of the C beta-sheet in the structure and function of alpha(1)-antitrypsin.
    Bottomley SP; Lawrenson ID; Tew D; Dai W; Whisstock JC; Pike RN
    Protein Sci; 2001 Dec; 10(12):2518-24. PubMed ID: 11714919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression screening of bacterial libraries of recombinant alpha-1 proteinase inhibitor variants for candidates with thrombin inhibitory capacity.
    Bhakta V; Gierczak RF; Sheffield WP
    J Biotechnol; 2013 Dec; 168(4):373-81. PubMed ID: 24140600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis in E. coli of alpha 1-antitrypsin variants of therapeutic potential for emphysema and thrombosis.
    Courtney M; Jallat S; Tessier LH; Benavente A; Crystal RG; Lecocq JP
    Nature; 1985 Jan 10-18; 313(5998):149-51. PubMed ID: 3880873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phage display of the serpin alpha-1 proteinase inhibitor randomized at consecutive residues in the reactive centre loop and biopanned with or without thrombin.
    Scott BM; Matochko WL; Gierczak RF; Bhakta V; Derda R; Sheffield WP
    PLoS One; 2014; 9(1):e84491. PubMed ID: 24427287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of heparin and glucose on structural conformation of human alpha1 antitrypsin: evidence for a heparin-induced cleaved form of the inhibitor.
    Finotti P; de Laureto PP
    Arch Biochem Biophys; 1997 Nov; 347(1):19-29. PubMed ID: 9344460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human alpha 1-proteinase inhibitor. Crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function.
    Loebermann H; Tokuoka R; Deisenhofer J; Huber R
    J Mol Biol; 1984 Aug; 177(3):531-57. PubMed ID: 6332197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant alpha 1-antitrypsin Pittsburgh (Met 358----Arg) is a potent inhibitor of plasma kallikrein and activated factor XII fragment.
    Schapira M; Ramus MA; Jallat S; Carvallo D; Courtney M
    J Clin Invest; 1986 Feb; 77(2):635-7. PubMed ID: 3484756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a human alpha1-antitrypsin variant that is as stable as ovalbumin.
    Lee KN; Im H; Kang SW; Yu MH
    J Biol Chem; 1998 Jan; 273(5):2509-16. PubMed ID: 9446551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the plasma elimination kinetics and conformational stabilities of native, proteinase-complexed, and reactive site cleaved serpins: comparison of alpha 1-proteinase inhibitor, alpha 1-antichymotrypsin, antithrombin III, alpha 2-antiplasmin, angiotensinogen, and ovalbumin.
    Mast AE; Enghild JJ; Pizzo SV; Salvesen G
    Biochemistry; 1991 Feb; 30(6):1723-30. PubMed ID: 1704258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and purification of recombinant human alpha1-proteinase inhibitor and its single amino acid substituted variants in Escherichia coli for enhanced stability and biological activity.
    Agarwal S; Jha S; Sanyal I; Amla DV
    J Biotechnol; 2010 May; 147(1):64-72. PubMed ID: 20346993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The transferable tail: fusion of the N-terminal acidic extension of heparin cofactor II to alpha1-proteinase inhibitor M358R specifically increases the rate of thrombin inhibition.
    Sutherland JS; Bhakta V; Filion ML; Sheffield WP
    Biochemistry; 2006 Sep; 45(38):11444-52. PubMed ID: 16981704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.